Pediatric Transplant and Oncology Infectious Diseases
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. v 5. Dedication - p. vi 6. Contributors - p. vii 7. Preface - p. viii 8. Foreword - p. ix 9. SECTION 1. General Immunocompromised Host Infection Principles - p. ix 10. 1. The surgical and immunosuppressive basis for infections in the pediatric solid organ transplant recipient - p. 1 11. 2. Immunologic recovery and basis for infections in the pediatric hematopoietic stem cell transplant recipient - p. 10 12. 3. Cancer and antineoplastic therapies and the risk of infection in the pediatric cancer patient - p. 22 13. SECTION 2. Common Immunocompromised Host Infection Situations - p. 33 14. 4. Infectious disease evaluation of infants and children awaiting solid organ or hematopoietic stem cell transplant - p. 34 15. 5. Donor screening and donor-derived infections - p. 40 16. 6. Prevention of infections in the hematopoietic stem cell transplant recipient - p. 46 17. 7. Prevention of infections in the solid organ transplantation recipient - p. 54 18. 8. Management principles for patients with neutropenia - p. 56 19. 9. Vaccination issues for transplantation and chemotherapy - p. 63 20. 10. Microbiome implications in transplantation and oncology - p. 71 21. 11. Antimicrobial stewardship in immunocompromised hosts - p. 78 22. 12. Hospital infection prevention for pediatric transplant recipients and oncology patients - p. 82 23. 13. Safe living after transplantation or chemotherapy - p. 90 24. SECTION 3. Specific Infections in Transplant Recipients and Oncology Patients - p. 96 25. 14. Multidrug-resistant gram-negative infections in transplant and oncology patients - p. 97 26. 15. Bartonella, Legionella, Mycoplasma, and Ureaplasma - p. 103 27. 16. Nontuberculous and tuberculous Mycobacterium - p. 109 28. 17. Cytomegalovirus - p. 118 29. 18. Epstein-Barr virus and posttransplant lymphoproliferative disorder - p. 126 30. 19. Herpes simplex and varicella-zoster viruses - p. 134 31. 20. Human herpesvirus 6, 7, and 8 - p. 142 32. 21. Respiratory viruses - p. 148 33. 22. Adenoviruses - p. 155 34. 23. BK and other polyomavirus associated diseases in children - p. 162 35. 24. Aspergillosis - p. 170 36. 25. Mucormycosis, fusariosis, scedosporiasis, and other invasive mold diseases - p. 181 37. 26. Candidiasis - p. 195 38. 27. Cryptococcosis and other rare invasive yeasts infections - p. 206 39. 28. Histoplasmosis, blastomycosis, and coccidioidomycosis - p. 214 40. 29. Toxoplasma gondii - p. 227 41. 30. Nocardia and Actinomyces - p. 233 42. 31. Pneumocystis pneumonia - p. 241 43. 32. Strongyloides, Cryptosporidium, and other parasitic infections - p. 247 44. 33. Gastrointestinal viruses - p. 253 45. 34. Clostridioides difficile infection - p. 258 46. Index - p. 263
Pediatric Transplant and Oncology Infectious Diseases
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. v 5. Dedication - p. vi 6. Contributors - p. vii 7. Preface - p. viii 8. Foreword - p. ix 9. SECTION 1. General Immunocompromised Host Infection Principles - p. ix 10. 1. The surgical and immunosuppressive basis for infections in the pediatric solid organ transplant recipient - p. 1 11. 2. Immunologic recovery and basis for infections in the pediatric hematopoietic stem cell transplant recipient - p. 10 12. 3. Cancer and antineoplastic therapies and the risk of infection in the pediatric cancer patient - p. 22 13. SECTION 2. Common Immunocompromised Host Infection Situations - p. 33 14. 4. Infectious disease evaluation of infants and children awaiting solid organ or hematopoietic stem cell transplant - p. 34 15. 5. Donor screening and donor-derived infections - p. 40 16. 6. Prevention of infections in the hematopoietic stem cell transplant recipient - p. 46 17. 7. Prevention of infections in the solid organ transplantation recipient - p. 54 18. 8. Management principles for patients with neutropenia - p. 56 19. 9. Vaccination issues for transplantation and chemotherapy - p. 63 20. 10. Microbiome implications in transplantation and oncology - p. 71 21. 11. Antimicrobial stewardship in immunocompromised hosts - p. 78 22. 12. Hospital infection prevention for pediatric transplant recipients and oncology patients - p. 82 23. 13. Safe living after transplantation or chemotherapy - p. 90 24. SECTION 3. Specific Infections in Transplant Recipients and Oncology Patients - p. 96 25. 14. Multidrug-resistant gram-negative infections in transplant and oncology patients - p. 97 26. 15. Bartonella, Legionella, Mycoplasma, and Ureaplasma - p. 103 27. 16. Nontuberculous and tuberculous Mycobacterium - p. 109 28. 17. Cytomegalovirus - p. 118 29. 18. Epstein-Barr virus and posttransplant lymphoproliferative disorder - p. 126 30. 19. Herpes simplex and varicella-zoster viruses - p. 134 31. 20. Human herpesvirus 6, 7, and 8 - p. 142 32. 21. Respiratory viruses - p. 148 33. 22. Adenoviruses - p. 155 34. 23. BK and other polyomavirus associated diseases in children - p. 162 35. 24. Aspergillosis - p. 170 36. 25. Mucormycosis, fusariosis, scedosporiasis, and other invasive mold diseases - p. 181 37. 26. Candidiasis - p. 195 38. 27. Cryptococcosis and other rare invasive yeasts infections - p. 206 39. 28. Histoplasmosis, blastomycosis, and coccidioidomycosis - p. 214 40. 29. Toxoplasma gondii - p. 227 41. 30. Nocardia and Actinomyces - p. 233 42. 31. Pneumocystis pneumonia - p. 241 43. 32. Strongyloides, Cryptosporidium, and other parasitic infections - p. 247 44. 33. Gastrointestinal viruses - p. 253 45. 34. Clostridioides difficile infection - p. 258 46. Index - p. 263
